CORDIS
EU research results

CORDIS

English EN
Personalized Medicine 2020 and beyond – Preparing Europe for leading the global way (PerMed)

Personalized Medicine 2020 and beyond – Preparing Europe for leading the global way (PerMed)

Objective

The Health Directorate of the European Commission's DG Research and Innovation recently stated that Personalized Medicine is one of the most innovative areas in the future of health research with a high potential for patients, citizens and the economy. However, today the full potential can not be developed due to fragmented activities, insufficient communication and lack of generic solutions in the different areas of Personalized Medicine.The implementation of Personalized Medicine is, therefore, a major challenge in Europe and beyond. It calls for appropriate governance strategies at the European and global level as it challenges the way in which healthcare systems worldwide are set up. Thus, the EC itself, EuroBioForum, the European Health Forum Gastein (EHFG) and others have organized conferences to tackle these challenges. Furthermore, key European organizations and institutions have come up with reports, guidelines, roadmaps aiming to give guidance in this emerging and important health research field amongst others the European Science Foundation (ESF) Forward Look, the Manifesto of the European Alliance for Personalised Medicine (EAPM), the European Best Practice Guidelines of the Public Health Genomics European Network (PHGEN), the Roche report on Personalized Medicine or the report of the European Hospital and Healthcare Federation (HOPE). Based on these initiatives European and national decision-makers and funding bodies not only have expressed the urgent need for a CSA, but also initiated this specific CSA to step up coordination efforts between the European key stakeholders to allow synergies and avoid duplication or competition, to ensure maximum transparency and openness preparing Europe for leading the global way.

Coordinator

DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV

Address

Linder Hoehe
51147 Koeln

Germany

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 187 506

Administrative Contact

Silke Kraus

Participants (17)

Sort alphabetically

Sort by EU Contribution

Expand all

BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG

Germany

ZORGONDERZOEK NEDERLAND ZON

Netherlands

EU Contribution

€ 29 639

FONDATION EUROPEENNE DE LA SCIENCE

France

MEDICAL RESEARCH COUNCIL

United Kingdom

EU Contribution

€ 16 585

INTERNATIONALES FORUM GASTEIN VEREIN

Austria

EU Contribution

€ 74 900

MINISTRY OF HEALTH

Israel

EU Contribution

€ 13 910

HELSINGIN YLIOPISTO

Finland

EU Contribution

€ 2 675

INSTITUTO DE SALUD CARLOS III

Spain

EU Contribution

€ 40 125

INSTITUT NATIONAL DU CANCER GIP

France

EU Contribution

€ 29 425

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU Contribution

€ 10 700

MINISTERO DELLA SALUTE

Italy

EU Contribution

€ 32 635

ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING MCGILL UNIVERSITY

Canada

EU Contribution

€ 19 260

UNIVERSITEIT MAASTRICHT

Netherlands

EU Contribution

€ 31 993

SOCIETE EUROPEENNE DE PHARMACOGENOMIQUE ET THERANOSTIQUE - EUROPEAN SOCIETY OF PHARMACOGENOMICS AND THERANOSTICS ASSOCIATION

France

EU Contribution

€ 2 675

FONDS NATIONAL DE LA RECHERCHE

Luxembourg

FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS

Spain

EU Contribution

€ 2 675

BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE

Germany

EU Contribution

€ 2 675

Project information

Grant agreement ID: 602139

Status

Closed project

  • Start date

    1 September 2013

  • End date

    31 August 2015

Funded under:

FP7-HEALTH

  • Overall budget:

    € 645 115

  • EU contribution

    € 497 378

Coordinated by:

DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV

Germany